Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with poor prognosis. In the last decades pirfenidone an anti-inflammatory and anti-fibrotic agent has shown benefit in inhibit collagen production and has also demonstrated benefit in decline progression in IPF in physiological outcomes as...

Descripción completa

Detalles Bibliográficos
Autores principales: Aravena, Carlos, Labarca, Gonzalo, Venegas, Carmen, Arenas, Alex, Rada, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550327/
https://www.ncbi.nlm.nih.gov/pubmed/26308723
http://dx.doi.org/10.1371/journal.pone.0136160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550327/
https://www.ncbi.nlm.nih.gov/pubmed/26308723
http://dx.doi.org/10.1371/journal.pone.0136160

Ejemplares similares